|
NeoPharm, Inc. - SWOT AnalysisPublished by: Datamonitor Published: Jul. 13, 2007 - 22 Pages Table of Contents
AbstractDatamonitor's NeoPharm, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.NeoPharm is a biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of cancer. The company has built its drug development program around its two technology platforms: a tumor-targeting toxin platform and NeoLipid liposomal drug delivery system. The company operates in Australia, Canada, Israel, Japan, New Zealand, South Africa, Switzerland and the US. It is headquartered in Waikegan, Illinois and employs about 50 people. The company recorded revenues of $.01 million during the fiscal year ended December 2006, a decrease of 98% over 2005. The operating loss of the company was $35.7 million during fiscal year 2006, compared to an operating loss of $40.2 million in 2005. The net loss was $33.2 million in fiscal year 2006, compared to a net loss of $38.7 million in 2005. Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||